Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · May 30, 2024

Re-Cellularization via Electroporation Therapy of the Duodenum Combined With GLP-1 Receptor Agonist for Type 2 Diabetes

Gastrointestinal Endoscopy


Additional Info

Gastrointestinal Endoscopy
Re-Cellularization via Electroporation Therapy of the duodenum combined with GPL-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes; 12 months results of a first-in-human study
Gastrointest. Endosc. 2024 Apr 29;[EPub Ahead of Print], CBE Busch, S Meiring, ACG van Baar, F Holleman, M Nieuwdorp, JJGHM Bergman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading